St. Petersburg Ebola Vaccine to Be Tested in Africa
Vaccine against haemorrhagic fever Ebola has been created in the St. Petersburg Influenza Research Institute. This was announced on Monday to TASS by the director of the Institute Oleg Kiselyov.
“The constructions are ready. Created by a group of young scientists of our institute, the candidate vaccine against Ebola was tested for genetic stability,” the official said. According to him, the vaccine will be called candidate before the completion of all tests and the commencement of commercial production.
Animal testing (preclinical trials) of vaccine will be held in the virological center of Ministry of Defense, the drug has already been sent there, Kiselev said.
The representatives of the Russian Ministry of Health will undertake clinical trials with the participation of volunteers in Africa. It is expected that all the stages of testing will be completed in February 2015, the director of the Institute said.